Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | FAAH | O00519 | 5/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Octyl Cyanoacrylate SCHEMBL24588 | 0.98 | FAAH (0.48) | TSHRALDH1A1FAAHCNR1CNR2 | |
| SCHEMBL28250919 | 0.98 | FAAH (0.48) | TSHRALDH1A1FAAHCNR1CNR2 | |
| SCHEMBL17142023 | 0.98 | FAAH (0.48) | TSHRALDH1A1FAAHCNR1CNR2 | |
| SCHEMBL1902715 | 0.95 | ALDH1A1 (0.49) | TSHRALDH1A1FAAHCNR1CNR2 | |
| 2-Octyl Cyanoacrylate SCHEMBL7867127 | 0.90 | FAAH (0.42) | TSHRALDH1A1FAAHCNR1CNR2 | |
| SCHEMBL15520224 | 0.88 | ALDH1A1 (0.52) | TSHRALDH1A1FAAHCNR1CNR2 | |
| SCHEMBL4581116 | 0.86 | TSHR (0.52) | TSHRALDH1A1FAAHCNR1CNR2 | |
| Hydroquinone SCHEMBL5278374 | 0.86 | ALDH1A1 (0.41) | TSHRALDH1A1FAAHCNR1CNR2 | |
| SCHEMBL28565955 | 0.85 | TSHR (0.44) | TSHRALDH1A1FAAH | |
| SCHEMBL3141579 | 0.84 | TSHR (0.47) | TSHRALDH1A1FAAHMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104704-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | FUNDACIÓ INSTITUT DE INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL (ES) | 2026-05-21 | — | — | WO | claimed |
| EP-4744687-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | Aesculap AG (DE) | 2026-05-20 | — | — | EP | claimed |
| WO-2026104704-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | FUNDACIÓ INSTITUT DE INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL (ES) | 2026-05-21 | — | — | WO | disclosed |
| EP-4744687-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | Aesculap AG (DE) | 2026-05-20 | — | — | EP | disclosed |
| US-20250339579-A1 | SURGICAL THREAD, SURGICAL SUTURE AND SURGICAL KIT | B BRAUN SURGICAL SA (ES) | 2025-11-06 | — | — | US | disclosed |
| EP-4531939-A1 | SURGICAL THREAD, SURGICAL SUTURE AND SURGICAL KIT | B. Braun Surgical, S.A. (ES) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023233011-A1 | SURGICAL THREAD, SURGICAL SUTURE AND SURGICAL KIT | B. BRAUN SURGICAL S.A. (ES) | 2023-12-07 | — | — | WO | disclosed |
| EP-4285946-A1 | SURGICAL THREAD, SURGICAL SUTURE AND SURGICAL KIT | B. Braun Surgical, S. A. (ES) | 2023-12-06 | — | — | EP | disclosed |
| US-20220160645-A1 | NANOPARTICLES COMPRISING COPOLYMERIC OR HOMOPOLYMERIC COMPOUNDS WHICH COMPRISE CYANOACRYLATE SUBUNITS | SINTEF TTO AS (NO) | 2022-05-26 | — | — | US | disclosed |
| EP-2708245-B1 | COMPOSITION, REACTION PRODUCT, KIT AND APPLICATOR, ESPECIALLY FOR USE IN MEDICINE | AESCULAP AG (DE) | 2019-03-20 | — | — | EP | disclosed |
| EP-2708245-A2 | Composition, reaction product, kit and applicator, especially for use in medicine | AESCULAP AG (DE) | 2014-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220160645-A1 | NANOPARTICLES COMPRISING COPOLYMERIC OR HOMOPOLYMERIC COMPOUNDS WHICH COMPRISE CYANOACRYLATE SUBUNITS | CD47, PSMA2, C3AR1 | TSHR 4838/4885ALDH1A1 1403/4885FAAH 3138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.